BRAF with or without MEK inhibition plus PD-1 checkpoint blockade for the treatment of metastatic melanoma.

被引：1
|
作者：
Rohlfs, Michelle [1 ]
Bassett, Roland L. [1 ]
Lacey, Carol [1 ]
McQuail, Natalie [1 ]
Mehta, Urvi [1 ]
John, Ida [1 ]
Simien, Rinata [1 ]
Tupue, Stephanie [1 ]
Dett, Tina Karin [1 ]
Glitza, Isabella Claudia [1 ]
Diab, Adi [1 ]
Amaria, Rodabe Navroze [1 ]
Tawbi, Hussein Abdul-Hassan [1 ]
Davies, Michael A. [1 ]
Hwu, Wen-Jen [1 ]
Hwu, Patrick [1 ]
Patel, Sapna Pradyuman [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.9548
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9548
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Resistance to PD-1 blockade in melanoma
    Burki, Talha Khan
    LANCET ONCOLOGY, 2016, 17 (09): : E376 - E376
  • [32] A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma
    Girault, Isabelle
    Adam, Julien
    Shen, Shensi
    Roy, Severine
    Brard, Caroline
    Faouzi, Sara
    Routier, Emilie
    Lupu, Jeremy
    Warren, Sarah
    Sorg, Kristina
    Ong, SuFey
    Morel, Pascale
    Scoazec, Jean-Yves
    Vagner, Stephan
    Robert, Caroline
    CLINICAL CANCER RESEARCH, 2022, 28 (03) : 518 - 525
  • [33] Beyond PD-1/PD-L1 Axis Blockade: New Combination Strategies in Metastatic Melanoma Treatment
    Giunta, Emilio Francesco
    Argenziano, Giuseppe
    Brancaccio, Gabriella
    Martinelli, Erika
    Ciardiello, Fortunato
    Troiani, Teresa
    CURRENT CANCER THERAPY REVIEWS, 2019, 15 (02) : 110 - 119
  • [34] The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
    Mahoney, Kathleen M.
    Freeman, Gordon J.
    McDermott, David F.
    CLINICAL THERAPEUTICS, 2015, 37 (04) : 764 - 782
  • [35] Mechanisms of Resistance to PD-1 Checkpoint Blockade
    Justin C. Moser
    Siwen Hu-Lieskovan
    Drugs, 2020, 80 : 459 - 465
  • [36] Mechanisms of Resistance to PD-1 Checkpoint Blockade
    Moser, Justin C.
    Hu-Lieskovan, Siwen
    DRUGS, 2020, 80 (05) : 459 - 465
  • [37] Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i
    Dummer, Reinhard
    Lebbe, Celeste
    Atkinson, Victoria
    Mandala, Mario
    Nathan, Paul D.
    Arance, Ana
    Richtig, Erika
    Yamazaki, Naoya
    Robert, Caroline
    Schadendorf, Dirk
    Tawbi, Hussein A.
    Ascierto, Paolo A.
    Ribas, Antoni
    Flaherty, Keith T.
    Pakhle, Neha
    Campbell, Catarina D.
    Gusenleitner, Daniel
    Masood, Aisha
    Brase, Jan C.
    Gasal, Eduard
    Long, Georgina, V
    NATURE MEDICINE, 2020, 26 (10) : 1557 - +
  • [38] Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i
    Reinhard Dummer
    Celeste Lebbé
    Victoria Atkinson
    Mario Mandalà
    Paul D. Nathan
    Ana Arance
    Erika Richtig
    Naoya Yamazaki
    Caroline Robert
    Dirk Schadendorf
    Hussein A. Tawbi
    Paolo A. Ascierto
    Antoni Ribas
    Keith T. Flaherty
    Neha Pakhle
    Catarina D. Campbell
    Daniel Gusenleitner
    Aisha Masood
    Jan C. Brase
    Eduard Gasal
    Georgina V. Long
    Nature Medicine, 2020, 26 : 1557 - 1563
  • [39] Anti-PD1 plus BRAF/MEK inhibitors (triplet therapy) after failure of standard therapy in patients (pts) with advanced melanoma.
    Zimmer, Lisa
    Dimitriou, Florentia
    Grover, Piyush
    Hassel, Jessica Cecile
    Erdmann, Michael
    Forschner, Andrea
    Johnson, Douglas Buckner
    Livingstone, Elisabeth
    Roesch, Alexander
    Ugurel, Selma
    Schulz, Carsten
    Berking, Carola
    Menzies, Alexander M.
    Long, Georgina V.
    Dummer, Reinhard
    Schadendorf, Dirk
    Albrecht, Lea Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
    Albrecht, Lea Jessica
    Dimitriou, Florentia
    Grover, Piyush
    Hassel, Jessica C.
    Erdmann, Michael
    Forschner, Andrea
    Johnson, Douglas B.
    Varaljai, Renata
    Lodde, Georg
    Placke, Jan Malte
    Krefting, Frederik
    Zaremba, Anne
    Ugurel, Selma
    Roesch, Alexander
    Schulz, Carsten
    Berking, Carola
    Poettgen, Christoph
    Menzies, Alexander M.
    Long, Georgina V.
    Dummer, Reinhard
    Livingstone, Elisabeth
    Schadendorf, Dirk
    Zimmer, Lisa
    EUROPEAN JOURNAL OF CANCER, 2024, 202
12345